To further test the therapeutic role of Akt isoform inhibition in GC-resistant B lymphocytes in vivo, we established an allograft model of SP2/0 cell line, a GC-resistant myeloma cell line of mouse. Here, AKT1 is linked to plasma cell myeloma.